Download PDF
Synlett 2010(15): 2311-2313  
DOI: 10.1055/s-0030-1258034
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

One-Pot Synthesis of Substituted Pyrimidine Derivatives from Acetylenedicarboxylate, Amine and Orthoformate

Arasampattu S. Nagarajan, Boreddy S. R. Reddy*
Industrial Chemistry Laboratory, Central Leather Research Institute, Adyar, Chennai 600 020, India
Fax: +91(44)24911589; e-Mail: induchem2000@yahoo.com;
Further Information

Publication History

Received 28 June 2010
Publication Date:
12 August 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

Substituted pyrimidine derivatives with a disubstituted pattern are produced in a novel one-pot reaction from diethyl(methyl)acetylenedicarboxylate, amine, and trimethyl(ethyl)orthoformate under solvent-free conditions using ZnCl2 catalyst.

Key words

solvent-free conditions - diethyl acetylenedicarboxylate - trimethyl orthoformate - pyrimidine

    References and Notes

  • 1a Dömling A. Ugi I. Angew. Chem. Int. Ed.  2000,  39:  3168 
    Google Scholar
  • 1b Ramon DJ. Yus M. Angew. Chem. Int. Ed.  2005,  44:  1602 
    Google Scholar
  • 2 Tietze LF. Chem. Rev.  1996,  96:  115 
    CrossrefPubMedGoogle Scholar
  • 3 Balme G. Bossharth E. Monteiro N. Eur. J. Org. Chem.  2003,  4101 
    CrossrefGoogle Scholar
  • 4a Orru RVA. de Greef M. Synthesis  2003,  1471 
    Google Scholar
  • 4b Weber L. Illgen K. Almstetter M. Synlett  1999,  366 
    Google Scholar
  • 5a Looper RE. Runnegar MTC. Williams RM. Angew. Chem. Int. Ed.  2005,  44:  3879 
    Google Scholar
  • 5b Kobayashi J. Kanda F. Ishibashi M. Shigemori H. J. Org. Chem.  1991,  56:  4574 
    Google Scholar
  • 5c Skinner GS. Wunz PR. J. Am. Chem. Soc.  1951,  73:  3814 
    Google Scholar
  • 6a Messer WS. Abuh YF. Liu Y. Periya Samy S. Ngur DO. Edgar MAN. El-Assadi AA. Sbeih S. Dunbar PG. Roknich S. Rho T. Fang Z. Ojo B. Zhang H. Huzl JJ. Nagy PI. J. Med. Chem.  1997,  40:  1230 
    Google Scholar
  • 6b Messer WS. Abuh YF. Ryan K. Shepherd MA. Schroeder M. Abunada S. Sehgal R. El-Assadi AA. Drug Dev. Res.  1997,  40:  171 
    Google Scholar
  • 6c Zhang H. Ojo B. Huang XP. Edgar MAN. El-Assadi AA. Baril D. Lynch K. Wahidy S. Messer WS. Life Sci.  1997,  60:  13 
    Google Scholar
  • 6d Dunbar PG. Durant GJ. Rho T. Ojo B. Huzl JJ. Smith DA. El-Assadi AA. Sbeih S. Ngur DO. Periyassamy S. Hoss W. Messer WS.
    J. Med. Chem.  1994,  37:  2774 
    Google Scholar
  • 6e Dunbar PG. Durant GJ. Fang Z. Abuh YF. El-Assadi MA. Ngur DO. Periyasamy S. Hoss W. Messer WS. J. Med. Chem.  1993,  36:  842 
    Google Scholar
  • 7 Malin G. Iakobashvili R. Lapidot A. J. Biol. Chem.  1999,  274:  6920 
    CrossrefGoogle Scholar
  • 8a Nair V. Chi G. Ptak R. Neamati N. J. Med. Chem.  2006,  49:  445 
    Google Scholar
  • 8b Zhou S. Kern ER. Gullen E. Cheng YC. Drach JC. Matsumi S. Mitsuya H. Zemlicka J. J. Med. Chem.  2004,  47:  6964 
    Google Scholar
  • 9 Pattarini R. Smeyne RJ. Morgan JI. Neuroscience  2007,  145:  654 
    CrossrefGoogle Scholar
  • 10a Nair AC. Jayatilleke P. Wang X. Miertus S. Welsh WJ. J. Med. Chem.  2002,  45:  973 
    Google Scholar
  • 10b De Lucca GV. Liang J. J. Med. Chem.  1999,  42:  135 
    Google Scholar
  • 11 Zhang M. Jiang H. Liu H. Zhu Q. Org. Lett.  2007,  9:  4111 
    CrossrefPubMedGoogle Scholar
  • 12 Huo C. Xiujum W. Huanfeng J. Qiuhua Z. Min Z. Haiyang L. Chem. Eur. J.  2008,  14:  11623 
    CrossrefGoogle Scholar
  • 13 Sasada T. Kobayashi F. Skai N. Konakahara T. Org. Lett.  2009,  11:  2161 
    CrossrefPubMedGoogle Scholar
14

General Procedure for Pyrimidine
To a stirred mixture of acetylenedicarboxylate 1 (2 mmol), amine 2 (4 mmol), and orthoformate 3 (2 mmol), ZnCl2 (0.5 mol%) was added successively at r.t. with vigorous stirring for 1-3 h. The precipitated solid was purified with a mixture of EtOAc-hexane (20:80 v/v). The product was further purified by recrystallization from EtOAc and found to be pure as indicated by TLC, ¹H NMR and ¹³C NMR data. Compound 4b: ¹H NMR (500 MHz, DMSO-d 6): δ = 1.09 (t, J = 6.9 Hz, 3 H), 3.77 (s, 6 H), 3.95 (s, 3 H), 4.13 (q, J = 7.6 Hz, 2 H), 5.29 (s, 1 H), 6.80-6.81 (m, 5 H), 6.88-6.90 (m, 4 H). ¹³C NMR (125 MHz, DMSO-d 6): δ = 14.2, 55.5, 59.8, 61.1, 62.0, 92.0, 114.3, 121.3, 123.4, 129.8, 133.6, 139.7, 149.5, 157.0, 164.4, 169.9. LCQ-MS (ESI): m/z (%) = 412. Anal. Calcd for C22H24N2O6: C, 64.07; H, 5.87; N, 6.79. Found: C, 64.19; H, 5.79; N, 6.91.
Compound 4h: ¹H NMR (500 MHz, DMSO-d 6): δ = 1.15 (t, J = 6.8 Hz, 3 H), 3.73 (s, 3 H), 4.18 (q, J = 6.8 Hz, 2 H), 5.56 (s, 1 H), 6.62 (s, 1 H), 6.64 (s, 1 H), 7.22-7.24 (m, 3 H), 7.49-7.50 (m, 2 H). ¹³C NMR (125 MHz, DMSO-d 6): δ = 14.4, 31.0, 60.4, 62.4, 97.3, 116.2, 122.3, 126.6, 130.1, 130.6, 131.2, 132.3, 136.9, 142.1, 146.2, 163.6, 169.1. LCQ-MS (ESI): m/z = 578. Anal. Calcd for C20H16Br2Cl2N2O4: C, 41.48; H, 2.79; N, 4.84. Found: C, 41.57; H, 2.93; N, 4.72.
Compound 4i: ¹H NMR (500 MHz, DMSO-d 6): δ = 1.13 (t, J = 6.9 Hz, 3 H), 2.19 (s, 6 H), 3.76 (s, 3 H), 4.11 (q, J = 6.8 Hz, 2 H), 5.61 (s, 1 H), 7.18 (s, 2 H), 7.33 (s, 3 H). ¹³C NMR (125 MHz, DMSO-d 6): δ = 14.4, 20.5, 60.1, 62.0, 92.4, 108.7, 121.9, 129.4, 132.2, 132.7, 135.7, 138.5, 139.6, 148.2, 162.6, 170.0. LCQ-MS (ESI): m/z = 696.1. Anal. Calcd for C22H20Br4N2O4: C, 37.96; H, 2.90; N, 4.02. Found: C, 37.85; H, 3.00; N, 4.13. Compound 4p: ¹H NMR (500 MHz, CDCl3): δ = 0.85 (t, J = 7.6 Hz, 6 H), 0.95 (t, J = 7.6 Hz, 3 H), 1.52-1.67 (m, 4 H), 3.10 (t, J = 7 Hz, 2 H), 3.38 (t, J = 6.9 Hz, 2 H), 3.70 (s, 3 H), 4.06 (q, J = 6.8 Hz, 2 H), 5.52 (s, 1 H), 6.86 (s, 1 H). ¹³C NMR (125 MHz, CDCl3): δ = 11.3, 11.4, 11.5, 21.9, 22.1, 29.8, 39.2, 61.1, 62.0, 83.7, 129.1, 140.0, 167.7, 172.8. LCQ-MS (ESI): m/z = 284.2. Anal. Calcd for C14H24N2O4: C, 59.13; H, 8.51; N, 9.85. Found: C, 59.02; H, 8.48; N, 9.86.